400 related articles for article (PubMed ID: 1104159)
1. The reactivity and carcinogenicity of aflatoxin B1-2,3-dichloride, a model for the putative 2,3-oxide metabolite of aflatoxin B1.
Swenson DH; Miller JA; Miller EC
Cancer Res; 1975 Dec; 35(12):3811-23. PubMed ID: 1104159
[TBL] [Abstract][Full Text] [Related]
2. Comparative aflatoxin B1 mutagenesis of Salmonella typhimurium TA 100 in metabolic and photoactivation systems.
Israel-Kalinsky H; Malca-Mor L; Stark AA
Cancer Res; 1984 May; 44(5):1831-9. PubMed ID: 6424931
[TBL] [Abstract][Full Text] [Related]
3. Immunological detection of aflatoxin B1-DNA adducts formed in vivo.
Hsieh LL; Hsu SW; Chen DS; Santella RM
Cancer Res; 1988 Nov; 48(22):6328-31. PubMed ID: 3141043
[TBL] [Abstract][Full Text] [Related]
4. Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo.
Swenson DH; Lin JK; Miller EC; Miller JA
Cancer Res; 1977 Jan; 37(1):172-81. PubMed ID: 187331
[TBL] [Abstract][Full Text] [Related]
5. Structural characterization of the major adducts obtained after reaction of an ultimate carcinogen aflatoxin B1-dichloride with calf thymus DNA in vitro.
Wood ML; Smith JR; Garner RC
Cancer Res; 1988 Oct; 48(19):5391-6. PubMed ID: 3138022
[TBL] [Abstract][Full Text] [Related]
6. DNA replication-blocking properties of adducts formed by aflatoxin B1-2,3-dichloride and aflatoxin B1-2,3-oxide.
Jacobsen JS; Refolo LM; Conley MP; Sambamurti K; Humayun MZ
Mutat Res; 1987 Jul; 179(1):89-101. PubMed ID: 3110609
[TBL] [Abstract][Full Text] [Related]
7. Comparative mutagenicity of palmotoxin Bo and aflatoxins B1 and M1.
Uwaifo AO; Emerole GO; Bababunmi EA; Bassir O
J Environ Pathol Toxicol; 1979; 2(4):1099-107. PubMed ID: 109559
[TBL] [Abstract][Full Text] [Related]
8. Excision repair of aflatoxin B1-DNA adducts in human fibroblasts.
Leadon SA; Tyrrell RM; Cerutti PA
Cancer Res; 1981 Dec; 41(12 Pt 1):5125-9. PubMed ID: 6796265
[TBL] [Abstract][Full Text] [Related]
9. Quantitative comparison of covalent aflatoxin-DNA adducts formed in rat and mouse livers and kidneys.
Croy RG; Wogan GN
J Natl Cancer Inst; 1981 Apr; 66(4):761-8. PubMed ID: 6939922
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity and mutagenicity of aflatoxin dichloride in normal and repair deficient diploid human fibroblasts.
Mahoney EM; Ball JC; Swenson DH; Richmond D; Maher VM; McCormick JJ
Chem Biol Interact; 1984 Jun; 50(1):59-76. PubMed ID: 6428759
[TBL] [Abstract][Full Text] [Related]
11. Removal of aflatoxin B1-DNA adducts and in vitro transformation in mouse embryo fibroblasts C3H/10T1 1/2.
Amstad PA; Wang TV; Cerutti PA
J Natl Cancer Inst; 1983 Jan; 70(1):135-9. PubMed ID: 6401827
[TBL] [Abstract][Full Text] [Related]
12. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases.
Kensler TW; Egner PA; Davidson NE; Roebuck BD; Pikul A; Groopman JD
Cancer Res; 1986 Aug; 46(8):3924-31. PubMed ID: 2873884
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic exposure to aflatoxin B1 and aflatoxin M1 on the in vivo covalent binding of aflatoxin B1 to hepatic macromolecules.
Loury DN; Hsieh DP
J Toxicol Environ Health; 1984; 13(4-6):575-87. PubMed ID: 6436500
[TBL] [Abstract][Full Text] [Related]
14. Comparative formation and removal of aflatoxin B1-DNA adducts in cultured mammalian tracheal epithelium.
Ball RW; Wilson DW; Coulombe RA
Cancer Res; 1990 Aug; 50(16):4918-22. PubMed ID: 2116221
[TBL] [Abstract][Full Text] [Related]
15. Resistance to aflatoxin B1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin.
Hayes JD; Judah DJ; Neal GE
Cancer Res; 1993 Sep; 53(17):3887-94. PubMed ID: 8395332
[TBL] [Abstract][Full Text] [Related]
16. Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformation.
Ramsdell HS; Eaton DL
Cancer Res; 1990 Feb; 50(3):615-20. PubMed ID: 2105159
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.
Kensler TW; Egner PA; Dolan PM; Groopman JD; Roebuck BD
Cancer Res; 1987 Aug; 47(16):4271-7. PubMed ID: 2886217
[TBL] [Abstract][Full Text] [Related]
18. Reduced nicotinamide adenine dinucleotide phosphate-dependent formation of 2,3-dihydro-2,3-dihydroxyaflatoxin B1 from aflatoxin B1 by hepatic microsomes.
Lin JK; Kennan KA; Miller EC; Miller JA
Cancer Res; 1978 Aug; 38(8):2424-8. PubMed ID: 27299
[TBL] [Abstract][Full Text] [Related]
19. Aflatoxin B1 carcinogenesis and its relation to DNA adduct formation and adduct persistence in sensitive and resistant salmonid fish.
Bailey GS; Williams DE; Wilcox JS; Loveland PM; Coulombe RA; Hendricks JD
Carcinogenesis; 1988 Nov; 9(11):1919-26. PubMed ID: 3141073
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of aflatoxin B1 and identification of the major aflatoxin B1-DNA adducts formed in cultured human bronchus and colon.
Autrup H; Essigmann JM; Croy RG; Trump BF; Wogan GN; Harris CC
Cancer Res; 1979 Mar; 39(3):694-8. PubMed ID: 427755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
